Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Zynerba Pharmaceuticals (United States) | Researchclopedia

Back to institutions

Zynerba Pharmaceuticals (United States)

Radnorcompany

28

Works

1,554

Citations

25

h-index

Top Research Topics

Cannabis and Cannabinoid Research Genetics and Neurodevelopmental Disorders Autism Spectrum Disorder Research

Top Researchers

Marcel O. Bonn‐Miller Charlotte's Web (United States)

219 works10,362 citationsh-index: 58

Recent Research

Long-Term Safety and Sustained Efficacy of ZYN002 Cannabidiol Transdermal Gel in the Treatment of Behavioral Symptoms in Children and Adolescents With Fragile X Syndrome (ZYN2-CL-017)

Nancy Tich,Anthony Thibodeau,et al.

20230 citations

Attention Deficit Hyperactivity Disorder

Epilepsy research and treatment

Pancreatic function and diabetes

Substance Abuse Treatment and Outcomes

Neurotransmitter Receptor Influence on Behavior

Neuroscience and Neuropharmacology Research

Pain Mechanisms and Treatments

Early Childhood Education and Development

Mindfulness and Compassion Interventions

Joseph S. Palumbo Cincinnati Children's Hospital Medical Center

195 works5,738 citationsh-index: 37

John A. Messenheimer

106 works5,057 citationsh-index: 38

Stephen O’Quinn BioInVision (United States)

43 works1,970 citationsh-index: 19

Donna Gutterman

31 works1,925 citationsh-index: 17

Joseph Palumbo Johnson & Johnson (United States)

64 works1,885 citationsh-index: 23

Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment

Joseph Palumbo,Brian F. Thomas,et al.

202325 citations

A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)

Elizabeth Berry‐Kravis,Randi J. Hagerman,et al.

202264 citations

Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy

Terence J. O’Brien,Samuel F. Berkovic,et al.

202225 citations

P154. Long-Term Safety and Sustained Efficacy of ZYN002 Cannabidiol Transdermal Gel in Children and Adolescents With Fragile X Syndrome (ZYN2-CL-017)

Nancy Tich,Anthony Thibodeau,et al.

20220 citations

RECONNECT (ZYN2-CL-033): DESIGN OF A PHASE 3 TRIAL OF ZYN002 CANNABIDIOL TRANSDERMAL GEL IN CHILDREN AND ADOLESCENTS WITH FRAGILE X SYNDROME BASED UPON LEARNINGS FROM CONNECT-FX (ZYN2-CL-016)

Joseph Palumbo,Nancy Tich,et al.

20212 citations